{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,2]],"date-time":"2026-05-02T23:40:41Z","timestamp":1777765241135,"version":"3.51.4"},"reference-count":11,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,5,14]],"date-time":"2024-05-14T00:00:00Z","timestamp":1715644800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JACC: CardioOncology"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1016\/j.jaccao.2024.05.006","type":"journal-article","created":{"date-parts":[[2024,6,18]],"date-time":"2024-06-18T14:20:35Z","timestamp":1718720435000},"page":"464-466","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Understanding Race, Genotype, and Socioeconomic Status in Transthyretin Amyloid Cardiomyopathy"],"prefix":"10.1016","volume":"6","author":[{"given":"Trejeeve","family":"Martyn","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julia M.","family":"Simkowski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mazen","family":"Hanna","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.jaccao.2024.05.006_bib1","first-page":"454","article-title":"Race and socioeconomic status impact diagnosis and clinical outcomes in transthyretin cardiac amyloidosis","volume":"6","author":"Shankar","year":"2024","journal-title":"J\u00a0Am Coll Cardiol CardioOnc"},{"issue":"2","key":"10.1016\/j.jaccao.2024.05.006_bib2","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.jacc.2016.03.596","article-title":"Genotype and phenotype of transthyretin cardiac amyloidosis: THAOS (Transthyretin Amyloid Outcome Survey)","volume":"68","author":"Maurer","year":"2016","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"1","key":"10.1016\/j.jaccao.2024.05.006_bib3","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1161\/CIRCULATIONAHA.118.038169","article-title":"Natural history, quality of life, and outcome in cardiac transthyretin amyloidosis","volume":"140","author":"Lane","year":"2019","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.jaccao.2024.05.006_bib4","first-page":"129","article-title":"Transthyretin V142I genetic variant and cardiac remodeling, injury, and heart failure risk in Black adults","volume":"10","author":"Coniglio","year":"2022","journal-title":"J\u00a0Am Coll Cardiol HF"},{"issue":"9","key":"10.1016\/j.jaccao.2024.05.006_bib5","first-page":"689","article-title":"Racial and genetic differences in presentation of transthyretin amyloid cardiomyopathy with impaired left ventricular function","volume":"10","author":"Martyn","year":"2022","journal-title":"J\u00a0Am Coll Cardiol HF"},{"key":"10.1016\/j.jaccao.2024.05.006_bib6","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.amjcard.2024.01.009","article-title":"Race, genotype, and prognosis in Black patients with transthyretin cardiac amyloidosis","volume":"216","author":"Khedraki","year":"2024","journal-title":"Am J Cardiol"},{"issue":"18","key":"10.1016\/j.jaccao.2024.05.006_bib7","doi-asserted-by":"crossref","first-page":"2354","DOI":"10.1016\/j.jacc.2019.02.042","article-title":"Disparities in cardiovascular mortality related to heart failure in the United States","volume":"73","author":"Glynn","year":"2019","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"6","key":"10.1016\/j.jaccao.2024.05.006_bib8","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1007\/s12170-021-00670-y","article-title":"Racial and ethnic disparities in transthyretin cardiac amyloidosis","volume":"15","author":"Spencer-Bonilla","year":"2021","journal-title":"Curr Cardiovasc Risk Rep"},{"issue":"5","key":"10.1016\/j.jaccao.2024.05.006_bib9","first-page":"350","article-title":"Trends in HF hospitalizations among young adults in the United States from 2004 to 2018","volume":"10","author":"Jain","year":"2022","journal-title":"J\u00a0Am Coll Cardiol HF"},{"issue":"6","key":"10.1016\/j.jaccao.2024.05.006_bib10","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.115.002558","article-title":"Transthyretin cardiac amyloidosis in Black\u00a0Americans","volume":"9","author":"Shah","year":"2016","journal-title":"Circ Heart Fail"},{"issue":"10","key":"10.1016\/j.jaccao.2024.05.006_bib11","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1001\/jamacardio.2022.1781","article-title":"A\u00a0simple score to identify increased risk of transthyretin amyloid cardiomyopathy in heart failure with preserved ejection fraction","volume":"7","author":"Davies","year":"2022","journal-title":"JAMA Cardiol"}],"container-title":["JACC: CardioOncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666087324001583?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666087324001583?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,24]],"date-time":"2024-06-24T19:54:56Z","timestamp":1719258896000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666087324001583"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":11,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,6]]}},"alternative-id":["S2666087324001583"],"URL":"https:\/\/doi.org\/10.1016\/j.jaccao.2024.05.006","relation":{},"ISSN":["2666-0873"],"issn-type":[{"value":"2666-0873","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Understanding Race, Genotype, and Socioeconomic Status in Transthyretin Amyloid Cardiomyopathy","name":"articletitle","label":"Article Title"},{"value":"JACC: CardioOncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaccao.2024.05.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.jaccao.2024.05.001","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier on behalf of the American College of Cardiology Foundation.","name":"copyright","label":"Copyright"}]}}